Modelis is a drug discovery platform company focused solely on rare, genetic diseases. Our unique approach combines genetically-engineered worms which are ‘avatars’ of human patients, with high-throughput drug screening. This results in a dramatically accelerated drug discovery process. Our platform is perfectly suited for genes that are evolutionarily and functionally conserved such as FIG4, and […]
Read More